[HTML][HTML] Selective autophagy regulates cell cycle in cancer therapy

K Zheng, Z He, K Kitazato, Y Wang - Theranostics, 2019 - ncbi.nlm.nih.gov
Aberrant function of cell cycle regulators results in uncontrolled cell proliferation, making
them attractive therapeutic targets in cancer treatment. Indeed, survival of many cancers …

p62/SQSTM 1—Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer

K Taniguchi, S Yamachika, F He, M Karin - FEBS letters, 2016 - Wiley Online Library
p62/SQSTM 1 is a multifunctional signaling hub and autophagy adaptor with many binding
partners, which allow it to activate mTORC 1‐dependent nutrient sensing, NF‐κB‐mediated …

[HTML][HTML] Altered glucose metabolism and cell function in keloid fibroblasts under hypoxia

Q Wang, P Wang, Z Qin, X Yang, B Pan, F Nie, H Bi - Redox biology, 2021 - Elsevier
Keloids exhibit metabolic reprogramming including enhanced glycolysis and attenuated
oxidative phosphorylation. Hypoxia induces a series of protective responses in mammalian …

Protein neddylation and its role in health and diseases

S Zhang, Q Yu, Z Li, Y Zhao, Y Sun - Signal Transduction and Targeted …, 2024 - nature.com
NEDD8 (Neural precursor cell expressed developmentally downregulated protein 8) is an
ubiquitin-like protein that is covalently attached to a lysine residue of a protein substrate …

Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway

ZG Zheng, ST Zhu, HM Cheng, X Zhang, G Cheng… - Autophagy, 2021 - Taylor & Francis
ABSTRACT SCAP (SREBF chaperone) regulates SREBFs (sterol regulatory element
binding transcription factors) processing and stability, and, thus, becomes an emerging drug …

Sequestosome 1/p62: A multitasker in the regulation of malignant tumor aggression

J Tang, Y Li, S Xia, J Li, Q Yang… - International …, 2021 - spandidos-publications.com
Abstract Sequestosome 1 (SQSTM1)/p62 is an adapter protein mainly involved in the
transportation, degradation and destruction of various proteins that cooperates with …

The emerging potential role of p62 in cancer treatment by regulating metabolism

X Zhang, M Dai, S Li, M Li, B Cheng, T Ma… - Trends in Endocrinology & …, 2023 - cell.com
Abstract p62 is an important multifunctional adaptor protein participating in autophagy and
many other activities. Many studies have revealed that p62 is highly expressed in multiple …

p62/SQSTM 1 as an oncotarget mediates cisplatin resistance through activating RIP 1‐NF‐κB pathway in human ovarian cancer cells

XY Yan, Y Zhang, JJ Zhang, LC Zhang, YN Liu… - Cancer …, 2017 - Wiley Online Library
Platinum‐based therapeutic strategies have been widely used in ovarian cancer treatment.
However, drug resistance has greatly limited therapeutic efficacy. Recently, tolerance to …

p62 acts as an oncogene and is targeted by miR-124-3p in glioma

D Deng, K Luo, H Liu, X Nie, L Xue, R Wang… - Cancer Cell …, 2019 - Springer
Background Glioma is the most common central nervous system (CNS) tumour. p62, an
important autophagy adaptor, plays a crucial role in cancer. However, the role of p62 in the …

[HTML][HTML] NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer

A Namani, QQ Cui, Y Wu, H Wang, XJ Wang, X Tang - Oncotarget, 2017 - ncbi.nlm.nih.gov
Mutations in Kelch-like ECH-associated protein 1 (KEAP1) cause the aberrant activation of
nuclear factor erythroid-derived 2-like 2 (NRF2), which leads to oncogenesis and drug …